Policy & Market
Sep 06, 2026 · 1 min read · 75,114 views
China sets ambitious goals for global drug and biotech expansion in new five-year plan
E
Elena Marsh
Editorial · Sep 06, 2026
China's new five-year plan targets 20% annual pharma revenue growth and a quarter of the world's first-in-class drugs by 2030
← Previous
In a changed world for cystic fibrosis, a family's fight reveals a new gap in care
Next →
Novartis' TREM2 drug fails Phase 2 ALS trial
